GondolaBio is seeking a development sciences leader to advance oligonucleotide and other novel modalities from target engagement to first‑in‑human and early clinical proof of concept. You will integrate nonclinical pharmacology, DMPK, biomarkers, clinical pharmacology, and quantitative sciences into a coherent development plan while staying hands‑on in a fast‑moving, early‑stage environment.
You will partner with Clinical Development, Regulatory, CMC, and Research to deliver integrated plans,
#J-18808-Ljbffr